REAL-WORLD ADHERENCE AND PERSISTENCE OF VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE CLAIMS ANALYSISREAL-WORLD ADHERENCE AND PERSISTENCE OF VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE CLAIMS ANALYSISREAL-WORLD ADHERENCE AND PERSISTENCE OF VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE CLAIMS ANALYSISREAL-WORLD ADHERENCE AND PERSISTENCE OF VIBEGRON IN PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE CLAIMS ANALYSIS

被引：0
|
作者：
Staskin, David [3 ]
Chastek, Benjamin [1 ]
Carrera, Adam [2 ]
Landis, Christina [1 ]
Snyder, Daniel [2 ]
Abedinzadeh, Laleh [2 ]
Bancroft, Tim [1 ]
Nesheim, Jeffrey [2 ]
机构：
[1] Optum, Eden Prairie, MN USA
[2] Urovant Sci, Irvine, CA USA
[3] Tufts Univ, Sch Med, Boston, MA USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2023年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
OM20
引用
收藏
页码：S164 / S165
页数：2
相关论文
共 50 条
  • [31] Biologic Treatment Adherence and Persistence in Patients with Palmoplantar Pustulosis: A Real-World, Claims-Based Study
    Feldman, Steven R.
    Gao, Ran
    Bohn, Rhonda L.
    Gray, Stephani
    Deruaz-Luyet, Anouk
    Wu, Jashin J.
    ADVANCES IN THERAPY, 2025, : 1994 - 2002
  • [32] Efficacy of vibegron in patients with overactive bladder: Multicenter prospective study of real-world clinical practice in Japan, SCCOP study 19-01
    Tachikawa, Kimihito
    Kyoda, Yuki
    Fukuta, Fumimasa
    Kobayashi, Ko
    Masumori, Naoya
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2022, 14 (02) : 109 - 116
  • [33] Evaluation of real-world persistence of propiverine and trospium chloride in treatment of overactive bladder in Germany
    Murgas, Sandra
    Adolf, Daniela
    RESEARCH AND REPORTS IN UROLOGY, 2019, 11 : 9 - 13
  • [34] Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents
    Lua, Lannah L.
    Pathak, Prathamesh
    Dandolu, Vani
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (08) : 2123 - 2131
  • [35] Real-world onabotulinumtoxinA treatment patterns in patients with overactive bladder
    Chughtai, Bilal
    Ricker, Christine N.
    Boldt, Ryan J.
    Elterman, Dean
    NEUROUROLOGY AND URODYNAMICS, 2024, 43 (02) : 396 - 406
  • [36] Re: Antimuscarinic Persistence Patterns in Newly Treated Patients with Overactive Bladder: A Retrospective Comparative Analysis Editorial Comment
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2015, 194 (04): : 1051 - 1051
  • [37] Real-World Persistence with and Adherence to Emicizumab Prophylaxis in Persons with Hemophilia a: A Secondary Claims Database Analysis
    Mahajerin, Arash
    Khairnar, Rahul
    Meyer, Craig S.
    Abbass, Ibrahim M.
    Wang, Rongrong
    Lee, Lucy
    Tzeng, Eunice
    Raimundo, Karina
    BLOOD, 2020, 136
  • [38] Efficacy and persistence of low-dose mirabegron (25 mg) in patients with overactive bladder: analysis in a real-world urological practice
    Yuan Chi Shen
    Hung Jen Wang
    Yao Chi Chuang
    International Urology and Nephrology, 2018, 50 : 1219 - 1226
  • [39] Efficacy and persistence of low-dose mirabegron (25 mg) in patients with overactive bladder: analysis in a real-world urological practice
    Shen, Yuan Chi
    Wang, Hung Jen
    Chuang, Yao Chi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (07) : 1219 - 1226
  • [40] Adherence and Persistence Among Multiple Sclerosis Patients After One Immunomodulatory Therapy Failure: Retrospective Claims Analysis
    Halpern, Rachel
    Agarwal, Sonalee
    Borton, Leigh
    Oneacre, Kathy
    Lopez-Bresnahan, Maria V.
    ADVANCES IN THERAPY, 2011, 28 (09) : 761 - 775
12345